Literature DB >> 24161430

Protective effect of Sheng-Nao-Kang decoction on focal cerebral ischemia-reperfusion injury in rats.

Lin Chen1, Ye Zhao2, Tianlong Zhang3, Xuan Dang1, Renming Xie1, Zhenzhi Li1, Yang Li1, Yuli Li1, Wenna Zhao1, Hongru Song4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Sheng-Nao-Kang decoction (SNK), a modified traditional Chinese medicine (TCM), has been used clinically for the treatment of acute and chronic cerebrovascular related diseases. To evaluate the protective effect of SNK on focal cerebral ischemia-reperfusion (I/R) injury in rats and investigate the underlying mechanisms.
MATERIALS AND METHODS: Focal cerebral I/R injury in rats was induced by middle cerebral artery occlusion (MCAO) for 2h followed by reperfusion for 24h. Adult male Sprague-Dawley (SD) rats were randomly divided into six kinds of groups: Sham group; I/R group; SNK-treated groups at doses of 0.7 g/kg, 1.4 g/kg and 2.8 g/kg; and nimodipine (NMP)-treated group. The recoveries of neurological function in rats were estimated by neurological defect scoring and 2,3,5-triphenyltetrazolium chloride (TTC) staining after 24h reperfusion. Various biochemical indexes in serum were assayed by colorimetry, including malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), inducible nitric oxide synthase (iNOS) and total nitric oxide synthase (TNOS). Histological structures of the brain in rats were observed by hematoxylin and eosin (H&E) staining. Immunohistochemistry was performed to detect the caspase-3 protein content in rats.
RESULTS: SNK administration significantly reduced the neurological defect scores and lessened the cerebral infarction volume. The treatment of SNK lowered MDA content, up-regulated SOD and GSH-Px levels, down-regulated iNOS and TNOS levels in serum. Furthermore, histological examination indicated that dense neuropil and largely surviving neurons were seen in SNK-treated rats. SNK administration restrained the expression of caspase-3 positive protein significantly.
CONCLUSION: The results suggest that SNK demonstrates a strong and ameliorative effect on cerebral I/R damage in rats. The protective mechanisms of SNK are associated with its properties of anti-apoptosis and anti-oxidation as well as regulation of iNOS and TNOS.
© 2013 Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  2,3,5-triphenyltetrazolium chloride; ANOVA; Anti-apoptosis; Anti-oxidation; CCA; ECA; Focal cerebral ischemia-reperfusion injury; GSH-Px; H&E; HPLC; I/R; ICA; IPP; Image-Pro Plus; MCAO; MDA; NMP; NO; RNS; ROS; S.E.M.; SD; SNK; SOD; Sheng-Nao-Kang decoction; Sprague-Dawley; TCM; TNOS; TTC; common carotid artery; external carotid artery; glutathione peroxidase; hematoxylin and eosin; high performance liquid chromatography; iNOS; inducible nitric oxide synthase; internal carotid artery; ischemia-reperfusion; malondialdehyde; middle cerebral artery occlusion; nimodipine; nitric oxide; one-way analysis of variance; p.o.; per os; reactive nitrogen radicals; reactive oxygen species; standard error of mean; superoxide dismutase; total nitric oxide synthase; traditional Chinese medicine

Mesh:

Substances:

Year:  2013        PMID: 24161430     DOI: 10.1016/j.jep.2013.10.015

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Zhongfeng Capsules protects against cerebral ischemia-reperfusion injury via mediating the phosphoinositide 3-kinase/Akt and toll-like receptor 4/nuclear factor kappa B signaling pathways by regulating neuronal apoptosis and inflammation.

Authors:  Chunlu Yan; Fangyu An; Jiayu Wang; Yao Shi; Lingqing Yuan; Donghui Lv; Yanzhen Zhao; Yongqi Liu; Yongfeng Wang
Journal:  Apoptosis       Date:  2022-06-08       Impact factor: 5.561

2.  Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats.

Authors:  Maha Mohammed Abdel-Fattah; Basim Anwar Shehata Messiha; Ahmed Mohamed Mansour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-17       Impact factor: 3.000

Review 3.  Chinese Medicinal Leech: Ethnopharmacology, Phytochemistry, and Pharmacological Activities.

Authors:  Han Dong; Ji-Xiang Ren; Jing-Jing Wang; Li-Shuai Ding; Jian-Jun Zhao; Song-Yan Liu; Hui-Min Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-04       Impact factor: 2.629

4.  Antifatigue Potential Activity of Sarcodon imbricatus in Acute Excise-Treated and Chronic Fatigue Syndrome in Mice via Regulation of Nrf2-Mediated Oxidative Stress.

Authors:  Xue Wang; Yidi Qu; Yongfeng Zhang; Shaopeng Li; Yiyang Sun; Zepeng Chen; Lirong Teng; Di Wang
Journal:  Oxid Med Cell Longev       Date:  2018-06-28       Impact factor: 6.543

5.  iTRAQ-Based Proteomics Analysis Reveals the Effect of Rhubarb in Rats with Ischemic Stroke.

Authors:  Xiangping Lin; Tao Liu; Pengfei Li; Zehui He; Yuanyuan Zhong; Hanjin Cui; Jiekun Luo; Yang Wang; Tao Tang
Journal:  Biomed Res Int       Date:  2018-07-16       Impact factor: 3.411

6.  Roots of Astragalus propinquus Schischkin Regulate Transmembrane Iron Transport and Ferroptosis to Improve Cerebral Ischemia-Reperfusion Injury.

Authors:  Juan Chen; Donglai Ma; Jun Bao; Ying Zhang; Guoxing Deng
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

Review 7.  Mitochondrial MPTP: A Novel Target of Ethnomedicine for Stroke Treatment by Apoptosis Inhibition.

Authors:  Yangxin Li; Jiayi Sun; Ruixia Wu; Jinrong Bai; Ya Hou; Yong Zeng; Yi Zhang; Xiaobo Wang; Zhang Wang; Xianli Meng
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

Review 8.  Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Authors:  Ping Huang; Haitong Wan; Chongyu Shao; Chang Li; Ling Zhang; Yu He
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.